Hobert Markus A, Nussbaum Susanne, Heger Tanja, Berg Daniela, Maetzler Walter, Heinzel Sebastian
Department of Neurology, Christian-Albrechts-University zu Kiel, Kiel, Germany.
Department of Neurodegenerative, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Front Aging Neurosci. 2019 Feb 13;11:22. doi: 10.3389/fnagi.2019.00022. eCollection 2019.
Gait changes occur during all Parkinson's disease (PD) stages and wearable sensor-derived gait parameters may quantify PD progression. However, key aspects that may qualify quantitative gait parameters as progression markers in PD remain elusive. Longitudinal changes in gait parameters from a lower-back sensor under convenient and challenging walking conditions in early- and mid-stage PD patients (E-PD, M-PD) compared to controls were investigated. Normal- and fast-pace parameters (step: number, time, velocity, variability) were assessed every 6 months for up to 5 years in 22 E-PD (<4 years baseline disease duration), 18 M-PD (>5 years) and 24 controls. Parameter trajectories and associations with MDS-UPDRS-III were tested using generalized estimating equations. Normal-pace step number (annual change in E-PD: 2.1%, TimeGroup: = 0.001) and step time variability (8.5%, < 0.05) longitudinally increased in E-PD compared to controls (0.7%, -12%). For fast pace, no significant progression differences between groups were observed. Longitudinal changes in M-PD did not differ significantly from controls. MDS-UPDRS-III was largely associated with normal-pace parameters in M-PD. Wearables can quantify progressive gait deficits indicated by increasing step number and step time variability in E-PD. In M-PD, and for fast-pace, gait parameters possess limited potential as PD progression markers.
步态改变出现在帕金森病(PD)的所有阶段,可穿戴传感器得出的步态参数或许能够量化PD的进展情况。然而,可能使定量步态参数成为PD进展标志物的关键因素仍不明确。研究了早期和中期PD患者(E-PD、M-PD)与对照组相比,在便捷和具有挑战性的步行条件下,来自下背部传感器的步态参数的纵向变化。在22例E-PD(基线疾病持续时间<4年)、18例M-PD(>5年)和24例对照组中,每6个月评估一次正常步速和快步行速参数(步数、时间、速度、变异性),持续5年。使用广义估计方程测试参数轨迹以及与MDS-UPDRS-III的相关性。与对照组(0.7%,-12%)相比,E-PD组正常步速的步数(E-PD组年度变化:2.1%,TimeGroup:=0.001)和步时间变异性(8.5%,<0.05)纵向增加。对于快步行速,未观察到组间有显著的进展差异。M-PD组的纵向变化与对照组无显著差异。在M-PD组中,MDS-UPDRS-III在很大程度上与正常步速参数相关。可穿戴设备能够量化E-PD组中步数增加和步时间变异性所表明的进行性步态缺陷。在M-PD组以及快步行速情况下,步态参数作为PD进展标志物的潜力有限。